<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.infectioninnovation.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://www.infectioninnovation.com/platforms/platform-1-bioactives-library-shaping-novel-products-and-therapies/</loc><lastmod>2026-09-05T14:51:00+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-2-developing-new-antibiotics/</loc><lastmod>2026-09-05T14:51:15+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-3-organoid-models/</loc><lastmod>2026-09-05T14:50:34+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-4-advanced-pk-pd-amr-modelling/</loc><lastmod>2026-09-05T14:51:24+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-5-human-challenge/</loc><lastmod>2026-09-05T14:51:59+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-6-diagnostics/</loc><lastmod>2025-10-27T15:28:43+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-7-randomised-control-trials/</loc><lastmod>2025-10-27T15:22:45+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-8-mapping-and-modelling/</loc><lastmod>2025-09-13T11:34:21+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-9-nanotherapeutics/</loc><lastmod>2025-10-27T15:30:54+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-10-antibody-humanisation/</loc><lastmod>2025-10-27T15:20:50+00:00</lastmod></url><url><loc>https://www.infectioninnovation.com/platforms/platform-11-long-acting-therapeutics/</loc><lastmod>2025-09-13T11:36:02+00:00</lastmod></url></urlset>
